Search company, investor...
Jaguar Animal Health company logo

Jaguar Animal Health



Total Raised


Date of IPO


Market Cap


Stock Price


About Jaguar Animal Health

Jaguar Animal Health is committed to bringing naturally derived important health solutions to all animals of the world, as pharmaceuticals, food additives, and nutraceuticals. Jaguar merges the high-value business model of companion and competitive animal care with the higher-volume economically driven business model applied to the food/farm animal marketplace. Jaguar expects to introduce its first products for animals experiencing watery diarrhea in 2014, both under its own label and in conjunction with private-label marketers.

Headquarters Location

185 Berry Street Suite 1300

San Francisco, California, 94107,

United States


Missing: Jaguar Animal Health's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Jaguar Animal Health's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Jaguar Animal Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Jaguar Animal Health is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Jaguar Animal Health Patents

Jaguar Animal Health has filed 7 patents.

patents chart

Application Date

Grant Date


Related Topics



Antacids, Ethology, Gastrointestinal tract disorders, Animal rights, Animal welfare


Application Date


Grant Date


Related Topics

Antacids, Ethology, Gastrointestinal tract disorders, Animal rights, Animal welfare



Latest Jaguar Animal Health News

Veterinary Auto-immune Disease Therapeutics Market | Pfizer Inc., Vet-Stem Inc., Ambrx Inc., Taconic Biosciences, Inc. | By 2032

May 19, 2023

. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period. The market for veterinary immunotherapeutics is anticipated to reach US$ 69010.77293 million in value by 2032, up from US$ 41087.71686 million in 2022, growing at a CAGR of 5.3% during that period. The use of veterinary auto-immune medicines is growing as novel methods for treating animal auto immune illnesses with various medications and other therapies, like as surgeries and stem cell treatments, are developed globally. Request Sample Report @ Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years. The team of analysts at Future Business Insights are focussing on research and market study to produce different Animal Auto-immune Disease Therapeutics Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Animal Auto-immune Disease Therapeutics Market. Ask an Analyst @ Key Players Some of the key players in global Animal Auto-immune Disease Therapeutics Market are Aratana Therapeutics Inc., Pfizer Inc., Vet-Stem, Inc., Ambrx Inc., Taconic Biosciences, Inc., JBS United, Virbac, Eli Lilly and Company, Jaguar Animal Health Inc. and many more. Segmentation By Therapy Type:

Jaguar Animal Health Frequently Asked Questions (FAQ)

  • Where is Jaguar Animal Health's headquarters?

    Jaguar Animal Health's headquarters is located at 185 Berry Street, San Francisco.

  • What is Jaguar Animal Health's latest funding round?

    Jaguar Animal Health's latest funding round is IPO.

  • How much did Jaguar Animal Health raise?

    Jaguar Animal Health raised a total of $11.62M.

  • Who are the investors of Jaguar Animal Health?

    Investors of Jaguar Animal Health include Delphi Ventures, BioVeda Capital and BVCF.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.